Firebird Biomolecular Sciences LLC

Alachua, FL

UEI
CTWDPXTLUAM7
CAGE
41NY5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
13709 Progress Blvd, Alachua, FL 32615, USA
Website
firebirdbio.com
Founded
2005
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $249,957

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Firebird Biomolecular Sciences LLC is a for-profit limited liability company registered in SAM.gov since 2005, located in Alachua, Florida. The company specializes in advanced molecular diagnostics, biotechnology research, and innovative DNA technologies with a focus on developing cutting-edge diagnostic and research solutions. The organization operates as a small business that leverages sophisticated molecular engineering techniques to create advanced diagnostic and research tools, particularly in the areas of viral detection, molecular diagnostics, and nucleic acid innovations.

Through federal contract awards, Firebird Biomolecular Sciences LLC has secured Small Business Innovation Research (SBIR) contracts, specifically with the Defense Health Agency (DHA). Their most recent contract, valued at $249,956.88, focuses on developing "Innovative DNA for Highly Multiplexed Molecular Diagnostics" with a specific emphasis on creating rapid, point-of-sampling entry tests for COVID-19 and other coronaviruses using an electrochemical detection approach. The contract is a firm-fixed-price award set aside for small businesses, with a performance period ending on May 8, 2025, demonstrating the company's commitment to innovative healthcare and diagnostic technologies for government agencies.

In the federal grant arena, Firebird Biomolecular Sciences LLC has received awards from multiple agencies, including the Office of Science, Office of the Director, and the National Institute of Allergy and Infectious Diseases. Their grant work has encompassed advanced research projects such as demonstrating the synthesis of large nucleotide pair constructs, developing reagents to chemically tag specific coronavirus spike proteins, and creating innovative molecular diagnostic technologies. Notable grant projects include a $250,000 Department of Energy grant focused on synthesizing 10,000+ nucleotide pair constructs and an NIH grant aimed at creating advanced diagnostic reagents for coronavirus detection. These grants highlight the company's expertise in molecular biology, genetic innovation, and developing sophisticated diagnostic technologies with potential broad applications in healthcare and research.

Quick answers

Is Firebird Biomolecular Sciences LLC registered in SAM.gov?

Yes. Firebird Biomolecular Sciences LLC's SAM.gov registration is active through January 12, 2027.

How much has Firebird Biomolecular Sciences LLC received in federal contracts?

Federal contracts obligated $249,957 to Firebird Biomolecular Sciences LLC in fiscal year 2025.

What is Firebird Biomolecular Sciences LLC's most recent federal award?

Firebird Biomolecular Sciences LLC's most recent federal contract award is DHA sbir phase 1 proposal H242-001-0085, "innovative DNA for highly multiplexed molecular diagnostics" (HT942525P0010), from Defense Health Agency, on October 9, 2024.

On GovTribe

See Firebird Biomolecular Sciences LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors